A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
This pharmacovigilance study uncovered new ocular and systemic AE signals associated with netarsudil, and found netarsudil-related AEs were more likely to arise shortly after drug administration, offering valuable insights for clinical monitoring, risk identification and future research.
Authors
- Xiaomei Xiong
- Fengmin Tang
- Taomin Huang (ORCID: https://orcid.org/0000-0001-5580-8371)
- Xiuwen Zhang (ORCID: https://orcid.org/0000-0002-9583-2672)
Institutions
- Eye & ENT Hospital of Fudan University (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1186/s40360-025-00927-x
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Fudan University
- Science and Technology Commission of Shanghai Municipality